 |
Keyword Search |
 |
|
|
| |
|
|
|
Return to American Society for Clinical Laboratory Science Events Library Menu
Your ASCLS membership log-in information will NOT work here. If you are a first time purchaser, please start by creating an account separate from your ASCLS membership.
Showing sessions 1 - 10 of (47) TOTAL sessions
(PREV 10) 1 2 3 4 5 (NEXT 10)
|
|
Event : ASCLS103 |
|
Session : ASCLS1101
Right Diagnosis, Right Laboratory Tests, Right on Time: Exploring the Challenges and Role of the Medical Laboratory Professional in the New Healthcare Environment
Opening Keynote - Session 1
Conference : 79th Annual Meeting
Speaker(s) :
|
Download Format(s) :
MP3,VIDEO | 
|
|
|
- Michael Laposata, MD, PhD, Pathologist-in-Chief,
Vanderbilt University Medical Center
James L. Meisel, MD, FACP, Assistant Professor
of Medicine, Boston University Medical Center
|
- This presentation will illustrate the challenges faced by
practicing clinicians on appropriate test selection and
correct interpretation of test results. The interactive
format will feature a laboratory director (Dr. Laposata)
and an internist (Dr. Meisel), discussing their sometimescompeting
challenges in optimizing the accuracy and
speed of a diagnosis involving laboratory tests.
|
- Investment Return:
Describe the competing challenges faced by
the laboratory director and primary care physisician
in test selection and results interpretation
Explain the role of the medical laboratory professional
in providing accurate test identification
guidance to the clinician Describe the potential risks and opportunities
that each of the case studies presents
to your clinical setting
|
- Earn P.A.C.E. credit
after viewing this session
|
Session : ASCLS1102
Bringing the Leadership Academy to You
Professional Development Session
Conference : 79th Annual Meeting
Speaker(s) :
|
Download Format(s) :
MP3,VIDEO | |
|
|
|
- Lynn Ingram, MLS; Demetra Castillo,
M.Ed., MLS (ASCP)CM, Rush University;
Chelsea Dockins, MBA, MLS (ASCP)CM,
Westroads Medical Center; Christina Goll,
MLS, St. John Macomb-Oakland Hospital;
Jessica Peters, MLS, Hennepin County Medical
Center; Charlotte Romain, MS, MLS(ASCP)CM,
Exosome Diagnostics
|
- This presentation will highlight the Leadership
Academys final project for FY 2010-11 to bring
the national Leadership Academy curriculum to
the state and local levels and to identify future
leaders of ASCLS at the state and local levels.
|
- Investment Return:
Review the curriculum of the national
Leadership Academy
Propose a curriculum to apply to the state
and local levels
Analyze the importance of identifying
potential leaders in ASCLS in accordance
with the mission of the organization
|
- Earn P.A.C.E. credit
after viewing this session
|
Session : ASCLS1103
How to Provide Vision, Set Goals and Focus Work for a More Productive Laboratory
Scientific Session 2
Conference : 79th Annual Meeting
Speaker(s) :
|
Download Format(s) :
MP3,VIDEO | |
|
|
|
- Karla Brandau, CSP, Workplace Power Institute
|
- Vague visions result in vague actions from your employees.
Learn to articulate a vigorous vision that creates broadbased
enthusiasm and support for your laboratory goals.
Follow the principles taught, and your concrete objectives
will keep employees steadily marching forward with their
eyes focused on the success indicators you have set.
|
- Investment Return:
Articulate a realistic vision of your laboratorys future
Write goals that provide direction for all employees
Move staff steadily forward to achievement
|
- Earn P.A.C.E. credit
after viewing this session
|
Session : ASCLS1104
Clinical Performance of Laboratory Tests
Scientific Session 3
Conference : 79th Annual Meeting
Speaker(s) :
|
Download Format(s) :
MP3,VIDEO | |
|
|
|
- Shahram Shahangian, PhD, DABCC, FACB,
Centers for Disease Control and Prevention (CDC)
|
- This presentation will address various issues relating to
clinical performance of laboratory tests in diagnostic and
screening contexts. Basic concepts related to laboratory
test performance and clinical validation will be presented,
including: disease heterogeneity, classification / test
referral bias, likelihood ratio and pre / posttest odds
ratios, predictive values and their relation to disease
prevalence, and selection of best combination test strategies.
Discussion will focus on 1) increasing clinical sensitivity
or clinical specificity and 2) decreasing number
of tests. Furthermore, evaluation of the clinical utility of
laboratory tests will be considered with regard to clinical
effectiveness, limitations and methodological biases.
|
- Investment Return:
Describe variables impacting clinical performance
of laboratory tests
Analyze biases impacting clinical performance
and implications of different test strategies
Evaluate clinical utility/limitations
of screening and diagnostic tests
|
- Earn P.A.C.E. credit after viewing this session
|
Session : ASCLS1105
A Ubiquitous Machine of Destruction: Targeting the Proteasome in Cancer
Scientific Session 4
Conference : 79th Annual Meeting
Speaker(s) :
|
Download Format(s) :
MP3,VIDEO | |
|
|
|
- Kristin Landis-Piwowar, PhD, MLS(ASCP),
Oakland University
|
- The proteasome is the heart of the ubiquitin-mediated protein
degradation pathway and is responsible for the breakdown
of most intracellular proteins. Proteasomal function is
crucial to biological homeostasis and regulation of numerous
cellular processes. Current concepts and applications of
proteasome inhibitors in cancer therapy will be discussed.
|
- Investment Return:
Describe the ubiquitin-proteasome pathway
List examples of critical homeostatic
pathways disrupted by proteasome inhibition
Discuss examples of proteasome inhibition
as therapeutic approaches to cancer
|
- Earn P.A.C.E. credit after viewing this session
|
Session : ASCLS1106
Pertussis in the 21st Century: The Laboratory Diagnostic Challenge Continues
Scientific Session 5
Conference : 79th Annual Meeting
Speaker(s) :
|
Download Format(s) :
MP3,VIDEO | |
|
|
|
- Maria Lucia Tondella, PhD, Centers for
Disease Control and Prevention (CDC)
|
- This session will present an overview of pertussis
diagnostics, including the challenges and current
improvements.
|
- Investment Return:
Describe current diagnostics methods for pertussis
Discuss challenges and pitfalls
Summarize current CDC efforts to improve
pertussis diagnostics
|
- Earn P.A.C.E. credit after viewing this session
|
Session : ASCLS1107
Productivity: How to Assess Performance and Manage Benchmarks
Scientific Session 6
Conference : 79th Annual Meeting
Speaker(s) :
|
Download Format(s) :
MP3,VIDEO | |
|
|
|
- Paul Camara, MS, Applied Medical Systems, Inc.
Rick Panning, MBA, MLS(ASCP)CM,
Allina Hospitals and Clinics
|
- Managing staffing levels and productivity is essential
for the viability of any healthcare provider. Although
productivity management often carries a negative connotation,
it can provide a tool for assessing current
performance, setting goals and providing the basis for
process improvement. This session will demonstrate
how consistent measurement of productivity enables a
culture of accountability. The laboratorys contribution
to organizational performance will provide the justification
for additional resources, and will help demonstrate
the value proposition for initatives such as student training
and quality efforts.
|
- Investment Return:
Discuss laboratory productivity benchmarks
and how to use them
Describe how non-testing activities such as
quality improvement and teaching can be quanified
and included in productivity benchmarks
Summarize the potential benefits of using
productivity benchmarking data to manage
your laboratory operations
|
- Earn P.A.C.E. credit after viewing this session
|
Session : ASCLS1108
Clinical Urine Drug Testing
Scientific Session 7
Conference : 79th Annual Meeting
Speaker(s) :
|
Download Format(s) :
MP3,VIDEO | |
|
|
|
- Roger L. Bertholf, PhD,
University of Florida College of Medicine
|
- Urine drug testing (UDT) in clinical settings, including
pain management and substance abuse recovery programs,
has become widespread. Laboratory services
that support UDT in clinical settings differ in many
important respects from forensic UDT. This session
reviews the unique aspects of clinical UDT and the
challenges they present to toxicology services.
|
- Investment Return:
Define clinical urine drug testing and list the
settings in which it is used
Explain the metabolism of opiates and summarize
the analytical strategies for detecting
opiate use
Describe the analytical approach to detecting
ethanol use in patients required to be abstinent
|
- Earn P.A.C.E. credit after viewing this session
|
Session : ASCLS1109
Carbapenem Resistant Enterobacteriaceae: Emergence, Detection and Prevention
Scientific Session 8
Conference : 79th Annual Meeting
Speaker(s) :
|
Download Format(s) :
MP3,VIDEO | |
|
|
|
- Brandi Limbago, PhD, Centers for Disease
Control and Prevention (CDC)
|
- This session will present a summary of common mechanisms
of carbapenem resistance among Enterobacteriaceae
(CRE) in the US, algorithmic approaches to identification
of resistance mechanisms and strategies to
prevent infections with CRE.
|
- Investment Return:
Describe the most carbapenem resistance mechanisms
among Enterobacteriaceae in the US
Summarize laboratory methods to identify carbapenemase
and metallo-beta-lactamase producers
Describe appropriate actions to take upon
detection/confirmation of CRE in the laboratory
|
- Earn P.A.C.E. credit after viewing this session
|
Session : ASCLS1110
Use of the Anti-Xa Assay to Dose Unfractionated Heparin (UFH)
Scientific Session 9
Conference : 79th Annual Meeting
Speaker(s) :
|
Download Format(s) :
MP3,VIDEO | |
|
|
|
- Karen Wrona, MT(ASCP), Diagnostica Stago, Inc.
|
- Unfractionated (UFH) and low molecular weight heparins
(LMWH) are widely used anticoagulants for the prevention
and treatment of venous thromboembolic disease. Characterized
by different pharmacological features and clinical
conditions, UFH or LMWH may require laboratory monitoring.
The most appropriate test to monitor heparin therapy
is the anti-Xa assay which has many advantages compared
to the activated Partial Thromboplastin Time (aPTT).
|
- Investment Return:
Discuss challenges of effectively monitoring
heparin therapy
List the benefits of the heparin anti-Xa assay
for monitoring heparin therapy
Identify the limitations of the aPTT assay
to monitor heparin therapy
|
- Earn P.A.C.E. credit after viewing this session
|
|
|
| |
|
|
Showing sessions 1 - 10 of (47) TOTAL sessions
(PREV 10) 1 2 3 4 5 (NEXT 10)
|
|
